Pneumology - Original Articles Open access

ABO blood group-dependent association of serum retinol-binding protein 4 with eosinophilic inflammation and spirometric parameters in adults with asthma

Authors

Published
16 October 2026
Issue
Early Access
Section
Pneumology - Original Articles
DOI
10.4081/monaldi.2026.4226

Abstract

Growing evidence links retinol binding protein-4 (RBP4) to inflammation; however, its association with inflammatory cell indices and spirometric parameters in asthma remains unclear, and the potential modifying role of ABO blood group has yet to be explored. The main aim was to assess the associations of serum RBP4 with inflammatory cell indices and spirometric parameters in adults with asthma stratified by blood group O and non-O.

Adults with physician-diagnosed asthma attending a respiratory clinic between January and June 2026 were consecutively enrolled in this cross-sectional study. Spearman's correlation assessed associations involving inflammatory cell indices, whereas Pearson's correlation evaluated associations between normally distributed serum RBP4 and spirometric parameters. Of the 88 adults with asthma enrolled, 64 had available ABO blood group data (38 O and 26 Non-O) and were included in the blood group-stratified analyses. In the O group, RBP4 was positively correlated with eosinophil count (ρ=0.35, p=0.03), eosinophil-to-neutrophil ratio (ρ=0.42, p<0.01), and eosinophil-to-lymphocyte ratio (ρ=0.41, p=0.01), whereas no significant associations were observed in the non-O group. Serum RBP4 was not correlated with spirometric parameters in either group. The forced expiratory volume in one second/forced vital capacity ratio was inversely correlated with eosinophil and lymphocyte counts only in the O group, while lymphocyte count showed an inverse correlation with forced expiratory flow between 25% and 75% of forced vital capacity in the non-O group. In conclusion, serum RBP4 was positively associated with eosinophilic inflammatory markers only in adults with asthma belonging to blood group O, whereas no such associations were observed in the non-O group.

Keywords

Ethics Approval

This cross-sectional study was approved by Ethical Committee for Clinical Studies at the Faculty of Medicine, University of Kufa under approval number MEC-10; January 7, 2026.

References

  1. Solomon Y, Malkamu B, Berhan A, et al. Peripheral blood eosinophilia in adult asthmatic patients and its association with the severity of asthma. BMC Pulm Med 2023;23:96. DOI: https://doi.org/10.1186/s12890-023-02383-x
  2. Lampalo M, Jukić I, Bingulac-Popović J, et al. ABO blood group genotypes and ventilatory dysfunction in patients with allergic and nonallergic asthma. Med Glas 2020;17:369-74. DOI: https://doi.org/10.17392/1099-20
  3. Lima-Matos A, Ponte EV, de Jesus JPV, et al. Eosinophilic asthma, according to a blood eosinophil criterion, is associated with disease severity and lack of control among underprivileged urban Brazilians. Respir Med 2018;145:95-100. DOI: https://doi.org/10.1016/j.rmed.2018.10.025
  4. Hamod A, Al-Mudhafar ZA. Influence of clinical biomarkers and demographic characteristics on predicted FEF25–75 in Iraqi patients with asthma. Babcock Univ Med J 2026;9:26-34. DOI: https://doi.org/10.38029/babcockuniv.med.j..v9i1.1165
  5. Moraes-Vieira PM, Yore MM, Dwyer PM, et al. RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance. Cell Metab 2014;19:512-26. DOI: https://doi.org/10.1016/j.cmet.2014.01.018
  6. Fan J, Hu J. Retinol binding protein 4 and type 2 diabetes: from insulin resistance to pancreatic β-cell function. Endocrine 2024;85:1020-34. DOI: https://doi.org/10.1007/s12020-024-03777-5
  7. Chang ML, Chen WT, Hu JH, et al. Altering retinol binding protein 4 levels in hepatitis C: inflammation and steatosis matter. Virulence 2020;11:1501-11. DOI: https://doi.org/10.1080/21505594.2020.1838742
  8. Steinhoff JS, Lass A, Schupp M. Retinoid homeostasis and beyond: how retinol binding protein 4 contributes to health and disease. Nutrients 2022;14:1236. doi:10.3390/nu14061236. DOI: https://doi.org/10.3390/nu14061236
  9. Zhang K, Wang L, Gao W, Guo R. Retinol-binding protein 4 in skeletal and cardiac muscle: molecular mechanisms, clinical implications, and future perspectives. Front Cell Dev Biol 2025;13:1587165. DOI: https://doi.org/10.3389/fcell.2025.1587165
  10. Huang F, Del-Río-Navarro BE, Torres-Alcántara S, et al. Adipokines, asymmetrical dimethylarginine, and pulmonary function in adolescents with asthma and obesity. J Asthma 2017;54:153-61. DOI: https://doi.org/10.1080/02770903.2016.1200611
  11. Kim BK, Song WJ, Seo B, et al. Retinol-binding protein-4 was associated with sensitization to inhalant allergens in the elderly population. Korean J Intern Med 2021;36:447-55. DOI: https://doi.org/10.3904/kjim.2019.348
  12. Leija-Martínez JJ, Patricio-Román KL, Del-Río-Navarro BE, et al. Retinol-binding protein 4 and plasminogen activator inhibitor-1 as potential prognostic biomarkers of non-allergic asthma caused by obesity in adolescents. Allergol Immunopathol 2021;49:21-9. DOI: https://doi.org/10.15586/aei.v49i3.73
  13. Park YH, Kim KW, Lee KE, et al. Clinical implications of serum retinol-binding protein 4 in asthmatic children. J Korean Med Sci 2009;24:1010-4. DOI: https://doi.org/10.3346/jkms.2009.24.6.1010
  14. Samarasinghe AE, Penkert RR, Hurwitz JL, et al. Questioning cause and effect: children with severe asthma exhibit high levels of inflammatory biomarkers including beta-hexosaminidase, but low levels of vitamin A and immunoglobulins. Biomedicines 2020;8:393. DOI: https://doi.org/10.3390/biomedicines8100393
  15. Dahalan NH, Tuan Din SA, Mohamad SMB. Association of ABO blood groups with allergic diseases: a scoping review. BMJ Open 2020;10:e029559. DOI: https://doi.org/10.1136/bmjopen-2019-029559
  16. Uwaezuoke SN, Eze JN, Ayuk AC, Ndu IK. ABO histo-blood group and risk of respiratory atopy in children: a review of published evidence. Pediatric Health Med Ther 2018;9:73-9. DOI: https://doi.org/10.2147/PHMT.S162570
  17. Bijanzadeh M, Ramachandra NB, Mahesh PA, et al. Lack of association between asthma and ABO blood group. Lung 2009;187:389-92. DOI: https://doi.org/10.1007/s00408-009-9175-1
  18. Çıldağ S, Kaman Ö, Sargın G, et al. Association of ABO Rh blood groups with allergic rhinitis and distribution according to allergen types. Asthma Allergy Immunol 2022;20:77-80.
  19. Özgen H, Tepetam FM, Bulut İ, Örçen C. The significance of eosinophil and eosinophil lymphocyte ratio (ELR) in predicting response to omalizumab treatment in patients with severe allergic asthma. Tuberk Toraks 2021;69:39-48. DOI: https://doi.org/10.5578/tt.20219905
  20. Chen J, Chen G, Xu X, et al. Retinol-binding protein 4 in cardiovascular diseases: mechanisms and therapeutic perspectives. Front Cardiovasc Med 2026;13:1703840. DOI: https://doi.org/10.3389/fcvm.2026.1703840
  21. Chen R, Li L, Li C, et al. Prealbumin and retinol-binding protein 4: the promising inflammatory biomarkers for identifying endoscopic remission in Crohn's disease. J Inflamm Res 2021;14:7371-9. DOI: https://doi.org/10.2147/JIR.S343125
  22. Nakajima H, Nakajima K, Tarutani M, Sano S. Clear association between serum levels of adipokines and T-helper 17-related cytokines in patients with psoriasis. Clin Exp Dermatol 2013;38:66-70. DOI: https://doi.org/10.1111/j.1365-2230.2012.04465.x
  23. Škrgat S, Harlander M, Janić M. Obesity and insulin resistance in asthma pathogenesis and clinical outcomes. Biomedicines 2024;12:173. DOI: https://doi.org/10.3390/biomedicines12010173
  24. Boonpiyathad T, Sözener ZC, Satitsuksanoa P, Akdis CA. Immunologic mechanisms in asthma. Semin Immunol 2019;46:101333. DOI: https://doi.org/10.1016/j.smim.2019.101333

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.

PlumX Metrics

License

Copyright (c) 2026 The Author(s)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.